191,787 page views of this website during 2018.
320,951 page views of this website between January 1st 2019 and May 31st 2019.
66,433 key individuals such as stakeholders, policymakers and academics throughout the EU and the rest of the world currently receive this publication.
For more details on the above please contact Stephanie Davies, our General Manager.
EU HEALTHCARE & SOCIAL CARE NEWS
Undiagnosed: are rheumatic and musculoskeletal diseases burdening the European taxpayer?
EULAR President Professor Johannes Bijlsma gives us an insight into the world of rheumatic and musculoskeletal diseases and the potential burden it could bring...
Virtual reality helps Hanover Scotland staff deliver better dementia care
“Incredibly Emotional” is the phrase housing association care staff in Moray have used to describe a virtual reality training session which helped bring improved...
No link discovered between cancer and tumour necrosis factor inhibitor
Including data from over 8,000 people, research suggests that there is no link between cancer and tumour necrosis factor inhibitor (TNFi) use in psoriatic...
Research shows public do not support exploitation of NHS patient data
According to YouGov, the UK public expect NHS patient data to be protected as a national asset that primarily benefits UK patients, the health...
Health inequality: NHS-funded private sector hip operations worsening
According to research, the impact of outsourcing NHS hip operations to the private sector concludes there is a widening health inequality occurring.
Researchers from Newcastle...
The budding opportunity in the $12 billion (~€10.6 billion) cannabis industry
Lux Research identifies the immense opportunities in the cannabis industry, and its about time the world pays attention to the innovative trends in the...
The world of cannabis tech: The medical cannabis inhaler
We speak to Jürgen Bickel, managing director at Storz & Bickel GmbH & Co. KG, who talks to us about the first and, to...
Discover the medtech startup’s taking on the world of medical cannabis
Now that medical cannabis is increasing its momentum across the world, more and more businesses are coming up with innovative ways of delivering patient...
The use of bisphosphonate to prevent loss of bone mineral density in post-menopausal women
Presented at the Annual European Congress of Rheumatology, study supports bisphosphonate use prior to denosumab to prevent loss of bone mineral density in post-menopausal...
Maximising vaccine effectiveness for children using genome-wide genotyping
Published in Cell Reports, genetics influence how protective childhood vaccines are, and researchers have found a way of maximising vaccine effectiveness using genome-wide genotyping.
A...
Unlocking EPR systems: digital transformation in healthcare
The focus on digital transformation in healthcare means that the majority of NHS trusts now have EPR systems in place – but now trusts...
Servelec extends digital care expertise into primary market
Servelec, a leading provider of digital care expertise, has announced its intention to enter the primary care space for the first time – could...
Latest Publication
Health Europa Quarterly Issue 09
Cannabis goes under the microscope in Health Europa Quarterly issue 09, which includes a special feature on the fast-evolving medical cannabis industry in Europe,...
Event Partners
EVENT PARTNERS
LATEST HEALTH EBOOKS
New Frontier Data – trusted cannabis industry research
New Frontier Data was founded in 2014 with the mission of collating and analysing data on the burgeoning cannabis industry.
Today the company operates across...
TILRAY: the medical cannabis research global leader
Medical cannabis is rapidly gaining momentum across the globe, and Tilray Inc. is pioneering the production, research, and distribution of medical cannabis.
This ebook explores...
Understanding mucopolysaccharide storage diseases
What are mucopolysaccharide storage diseases? What are their signs and symptoms? And what treatment options are available for patients?
These are just some of the...
Institute for Cardiogenetics – unravelling the genetics of cardiovascular disease
Cardiovascular disease (CVD) is a major global killer, but little is known about the exact causes. The Institute for Cardiogenetics aims to understand the...
LATEST PARTNERS
Explore the world of Medical cannabis production, with Holigen
Introducing Holigen, a future leader in large-scale, low-cost and high-quality cannabis production from a GMP compliant facility in the EU.
Holigen adopts a holistic approach...
Neurosteer and the research being done to tackle neurological disorders
Neurosteer Inc.
Neurosteer™ has developed a solution for the early detection and more effective treatment of a variety of neurological disorders.
It consists of a medical-grade...
Regenerative gene therapies with the potential to transform respiratory medicine
Discover OmniSpirant, the innovative company of experts in the fields of pulmonary gene therapies, cell-free regenerative medicine and respiratory medicine.
OmniSpirant is an Irish company...
Tetra Bio-Pharma and cannabinoid-derived pharmaceuticals
Canadian-based Tetra Bio-Pharma is taking a pharmaceutical pathway to discover and develop cannabinoid-derived pharmaceuticals.
Being a global biopharmaceutical leader in cannabinoid-based drug discovery and development,...
